Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin in the Treatment of Mixed Nocturia
NCT00902655Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Apr 2004
- Primary completion
- Dec 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of desmopressin in nocturia, sponsored by Samsung Medical Center. Primary endpoint: Proportion of patients with a 50% or greater reduction in the mean number of nocturnal voids compared with baseline levels at 4 weeks. Started Apr 2004; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT00902655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902655.